WHO <br/><br/>
HIV drug resistance Early warning indicators 

 - Geneva,Switzerland  (WHO)World Health Organization  2010 
 - 45p 
<br/><br/> Describes the key element in the recommended HIV Drug Resistance prevention and assessment strategy by the WHO which includes: ART site based HIV Drug Resistance (HIVDR) Early Warning Indicators. Includes indicators such as ART prescribing practices, patients lost to follow-up 12 months after ART initiation, patients on appropriate first-line ART at 12 months, on-time ARV drug pick-up, ART clinic appointment keeping, ARV drug supply continuity, optional early warning indicators. Demonstrates how results can inform national decision-making on ART programme planning and other HIV drug resistance prevention measures. 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drugs|Art|Human immunodeficiency virus|Drug Resistance|Treatment
<br/><br/><label>LC Class. No.: </label>WC503.2 W 46 2010